Funding awarded
- Lorenzo Foffano American-Italian Cancer Foundation (AICF) for the period 2025-2026 awarded by American Italian Cancer Foundation Principal Investigator 2026 - 2027
- Early detection blood test for universal breast cancer screening to improve early diagnosis for women of all social and ethnic backgrounds awarded by United States Department of Defense Principal Investigator 2024 - 2027
- A Program for Metastatic Breast Cancer Research awarded by METAvivor Research and Support, Inc. Principal Investigator 2023 - 2026
- Development of a platform for high throughput drug screening on CTC-derived organoid in breast and colorectal cancer Principal Investigator 2022 - 2025
- The association of HER2 expression on circulating tumor cells with the response to cyclin-dependent kinase 4/6 inhibitors in hormone receptor positive, HER2 negative metastatic breast cancer awarded by The Asco Cancer Foundation Principal Investigator 2023 - 2024
- Personalized in vitro models to advance precision health equity awarded by National Cancer Institute Co-Investigator 2024 - 2026